Clever Leaves Holdings Inc (CLVR)

[THEMASTERS_SON]

,,,,,,HOLD $5-$10

[noodle]

i am in with a few shares, lets see what it does here!!!

[diduknow]

LOL, warned u about this long ago, and that chucklehead misteroldman. Back in mommies basement he is.

[kahlua]

Since Q3 ER the stock has fallen just under 60% - it is now valued at a market cap of $72M.
CLVR now trades at price to book ratio of .82
Compare that with closest peer PCLO which trades at a market cap of $115M US. The comparison differential is even wider if you calculate their current EV’s.
So why has CLVR underperformed its best comparable peer despite arguably better “on paper” assets and a competitive advantage? (CLVR has had EUGMP, bigger cultivation footprint in Columbia and their Portugal flower operation). My guess is CLVR lost significant credibility this last year reducing guidance twice. It also cannot be ignored that PCLO has a much deeper “cannabis veterans” bench than CLVR with board and execs connected in some way to Cresco, Verano, Curaleaf (Emmac) and IM Cannabis. CLVR’s board and executive team is not built to create big cannabis link up opportunities the way PCLOs was. I view this as a key mistake when the team was put together. They should have at least added one big cannabis name to their board.
Curious if others are following this one and if you have insights or thoughts on this. Perhaps I’m missing something.
Cheers!

[trickledownfacists]

Yup

[trickledownfacists]

New weed favorite

[trickledownfacists]

Yup. Cheap

[trickledownfacists]

This is a steal under $8

[aries4747]

CLVR Clever Leaves to Take Advantage of the Approval to Export Medical Cannabis Flower from Colombia

July 23 2021 - 05:46PM
GlobeNewswire Inc.


Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, hosted Colombian President Duque at its cultivation facility in Colombia for the signing of a new decree that allows Colombian licensed cannabis companies such as Clever Leaves to participate in the commercial production and export of medical cannabis flower. With flower representing an estimated 50% of the global medical cannabis markets, this decree doubles the total addressable market for Colombian cannabis producers.

Clever Leaves is well-positioned to take advantage of this opportunity to export dried cannabis flower, leveraging its 1.8 million sq. ft. CUMCS GACP certified cultivation facility, its EUGMP Part II certification covering the production of dry flower, and its 30-plus cannabinoid genetics registered in the country. Colombia’s environmental conditions, coupled with Clever Leaves’ experience in sustainable cannabis growing, will allow the company to bring to market unique products with pharmaceutical quality. Colombian flower complements Clever Leaves’ already strong Portuguese flower production, allowing the company to present a comprehensive portfolio, covering different strains and growing conditions, that will suit ever-evolving patient needs.

Having shipped cannabis products to over 15 countries in five continents, Clever Leaves has a strong network of partners globally, who will benefit from its broader flower offering. Clever Leaves will leverage its position as a trusted B2B partner to develop and produce high quality and innovative products for medical cannabis patients around the world.

This change in regulation, allowing for the export of dried flower, will catalyze the continued development of the Colombian medical cannabis industry by eliminating the restriction that blocked access to 50% of the global medical cannabis market. In addition, the decree includes features that will help Clever Leaves to drive additional growth, including streamlined processes in quota management systems, which enable efficiencies and improve Clever Leaves’ ability to serve clients faster. The bill also includes access to medical cannabis for patients in Colombia.

During the visit to Clever Leaves’ facilities, President Duque, who was accompanied by several of his ministers, regional and local authorities, highlighted the expected impact of this to the country: “This new decree represents an important milestone for Colombia, enabling us to compete in international markets. Furthermore, the decree raises the standards of our products and adds significant value, particularly in the medicinal sector. Clever Leaves has served as a benchmark for the Colombian cannabis industry, generating 17 employments per hectare at its cultivation facility. I encourage our government representatives across various entities to unite and further support the development of the industry.”

Kyle Detwiler, CEO at Clever Leaves said: “The change in policy by the Colombian government could double our addressable market from Colombia, a region where Clever Leaves has made a substantial capacity investment but where we have been limited in only selling processed or extracted products up to this point in time. Nevertheless, since 2016, we have been building the capabilities required to produce a pharmaceutical-grade product.

“This regulatory evolution will enable us to better serve our customers around the world by capitalizing on Latin America’s only EU GMP certified cannabis operation, which, much to many peoples’ surprise, already includes EU GMP certified dry flower production. In hopeful anticipation of this moment, our team has spent the past several years developing commercial relationships, market insights and supply partnerships globally, and this catalyst will hopefully unlock significant potential of our gradually expanding customer base. Through our Portuguese dry flower production facility, we have learned and successfully navigated the different challenges facing a flower operation, including quality requirements, GACP and EU GMP certifications, sterility protocols, import/export logistics of psychoactive product, and cannabinoid potency requirements, many of which are different from that of processed or extracted products. We hope these lessons and relationships allow Clever Leaves to capitalize on Colombia’s new cannabis regulations.”

___________________________________
1 Market size estimates calculated from data reported in:

Grandview Industry Analysis, Legal Marijuana Market Size, Share & Trends Analysis Report By Marijuana Type (Medical, Adult Use), By Product Type (Flower, Oil), By Medical Application (Chronic Pain, Mental Disorders), And Segment Forecasts, 2021 – 2028. May 2021
BDS Analytics, Arcview Market Research, The State of Legal Cannabis Markets, 7th Edition, 2020 Update.


About Clever Leaves Holdings Inc.

Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute - Invima, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from Infarmed – the Portuguese health authority – which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was granted certification of compliance with GACP and IMC-GAP.

For more information, please visit https://cleverleaves.com/en/home/ and follow us on LinkedIn.

Clever Leaves Investor Inquiries:
Cody Slach and Jackie Keshner
Gateway Investor Relations
[phone]
[e-mail]

Clever Leaves Press Contacts:
McKenna Miller
KCSA Strategic Communications
[phone]
[e-mail]

Diana Sigüenza
Strategic Communications Director
[phone]
[e-mail]

Clever Leaves Commercial Inquiries:
Andrew Miller
Vice President Sales - EMEA, North America, and Asia-Pacific
[phone]
[e-mail]

[aries4747]

Citigroup Inc. Acquires New Holdings in Clever Leaves Holdings Inc. (NASDAQ:CLVR)
Posted by Logan Wallace on Jul 23rd, 2021


Clever Leaves logoCitigroup Inc. acquired a new stake in Clever Leaves Holdings Inc. (NASDAQ:CLVR) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,948 shares of the company’s stock, valued at approximately $123,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. UBS Group AG acquired a new stake in Clever Leaves in the 1st quarter valued at about $43,000. Wells Fargo & Company MN acquired a new stake in Clever Leaves in the 4th quarter valued at about $50,000. Vontobel Holding Ltd. acquired a new stake in Clever Leaves in the 4th quarter valued at about $142,000. Symons Capital Management Inc. purchased a new position in Clever Leaves in the 1st quarter valued at about $184,000. Finally, JPMorgan Chase & Co. purchased a new position in Clever Leaves in the 1st quarter valued at about $216,000. 19.53% of the stock is currently owned by hedge funds and other institutional investors.
Get Clever Leaves alerts:
NASDAQ:CLVR opened at $9.07 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.44 and a current ratio of 2.82. The company has a 50-day moving average price of $10.04. Clever Leaves Holdings Inc. has a 12-month low of $7.95 and a 12-month high of $19.46.
Clever Leaves (NASDAQ:CLVR) last released its earnings results on Monday, May 17th. The company reported ($0.36) earnings per share (EPS) for the quarter. The business had revenue of $3.48 million for the quarter.
Clever Leaves Profile
Clever Leaves Holdings Inc cultivates, extracts, manufactures, and commercializes pharmaceutical-grade cannabinoid products in Colombia, Portugal, Germany, the United States, and Canada. The company operates through two segments, Cannabinoid and Non-Cannabinoid. It also engages in the formulating, manufacturing, marketing, distributing, and selling of homeopathic and other natural remedies, wellness products, detoxification products, nutraceuticals, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors.
Read More: Diversification Important in Investing
Want to see what other hedge funds are holding CLVR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clever Leaves Holdings Inc.

[kahlua]

The stock price is up 50% in barely a week and no comment here. I’ve been long since pre despac so I’m very aware of how this stock trades and this week was very different. Below is what I wrote on another message board. Just food for thought.

Per fintel the short volume as a percent of traded volume collapsed in the last few days to very low levels, so the shorts are leaning far away from this very steep move which suggests they know something , as normally they’d aggressively lean into it. The sector has not run up near as much as CLVR this week (unlike the February run up which was sector wide) so I just don’t think this is due to a possible decriminalization bill finally coming to the Senate floor. If this were a newsletter or analyst recommendation I could certainly see a one or two day run up but nothing like the activity we’ve seen the last week. Oversold rallies rarely go from oversold relative strength and money flow to almost overbought in barely a week on no news announcement and without similarly strong moves within the sector. Earlier in the week when I saw GME and AMC were again on a tear, it made me wonder if this run up in CLVR was the wall street bets group piling in (I have not been able to verify it). So, having ruled out most possibilities, if it’s not the WSB group then I think a very significant announcement is forthcoming possibly even a buyout or merger of some sort. Adding to the mystery, the warrants are at $2.55 on Fridays close but they were well over $3 the last time the commons were in this low $12 range, so either the warrants are undervalued and will catch up or this reduced spread differential is telling a bigger story...that the $11.50 strike is keeping a tight leash on the warrants pending forthcoming news. . Curaleaf just bought EMMAC for 286M to position itself for EU growth in coming years. So what would a company pay for CLVR to be able to position itself in a similar manner in the EU plus gain huge exposure to the entire Latam region? Anything less than 500M would be a really bad deal for investors imo. Just spit balling here but this latest activity is way out of the norm since its despac.

[misteroldman]

This board sucks

[misteroldman]

How are you not making money in this?! Trades like clockwork. I feel bad for you actually. You mad bro?? You just a little boy scared Bag holding and lost money? Ouch. Sucks, happens. More often to you. But not every trade is a winner. This stock is tho

[diduknow]

Move back to mommy's basement Mr. New high, GMP certified, lowest cost per gram moron. You have been schooled, look at like a tuition payment you dolt. New low today, not new high. You are now a long term shareholder, I hope it works out for you but as far as your daily candlestick reading, well, you failed that lesson. Learn how to read financial statements or you'll be sucking mommies teet forever.

[misteroldman]

ROFL dont hurt your brain reading, kiddo. LOL you think its just candlesticks that is charting? exactly why you dont know how to chart. And why I sold in the 11s and waited until now to buy big and jump back in. This is reversal time. You dont know a thing diduknow. LOL u think you are smart and "messing with me" but joke is on you kiddo. You post ZERO substance and rely on others DD. I clearly stated I use candlesticks to confirm reversals only, LIKE ALL US PROs. I am a retired wealth manager... lol what are you? unemployed playing with money you cant afford to lose? ROFL at people like you who are so arrogant and ignorant that you seclude yourself in your social media bubbles and seek confirmation from stranger that you being toxic to others and making fun of others is truly funny so you feel better about yourself. Truth is, you hate yourself just like 99% of the world struggles with their self esteem and self worth thanks to how social media has diminished your mind along with everyone else. Society is full of uneducated humans who are just educated enough and connected enough through technology to use SEO sites to make yourself feel more empowered and smarter than you really are causing you to blind yourself from your actual self worth. You are vain and shallow. It reeks from your posts and the uneducated part of you is hilarious. You need help in life, you will need it. I am guessing you are very alone in this world and have no real friends and not married. Maybe divorced but that might even be giving you too much credit. It is fun putting you in your place once a week tho. You are so novice and know literally nothing about life and how money flows. You think you know, but you are still having to grow up a lot kiddo. rofl at you needing to be toxic because you are insecure with who you are as a person. VERY SAD

[kahlua]

I stand by my lower range expectation. Earnings were a yawn and Q2 numbers will be more of the same. 130M of pre-spac invested capital built and bought a solid underlying asset base from the US to Columbia, Portugal and Germany. Add that asset portfolio to cash on hand and that yields a roundabout EV floor for the stock. Unless the market tanks I’d expect low 8’s to see buyer demand. The bigger picture really doesn’t begin to emerge until the 2H and 2022 visibility will be crucial to whether the Ho hum story finally changes (that or US decriminalization).

[diduknow]

Pretty close to your assessment but for lower bound trading range over the next 6 mos. Far more due diligence on your part than Mr. Candlestick, new highs, no due diligence cheerleader, who at this point, has one stuck in his hiney and has no choice but to be a long term shareholder or sell.

[kahlua]

I agree, losses will continue every quarter this year, at least. I’m expecting a cash burn rate around $10M for Q1. I think they will exit 2021 with maybe $40M cash after a year of very high opex and $10M capex.

Receivables will be fine. Herbal brands is still predominantly the revenue generator for at least 1H of 2021 and GNC was bought out and there are no longer inventory reserve issues. Why are you expecting a quarterly report delay? The company just announced earnings release and conference call for May 17th.

Yes the 8K regarding the restated financials was posted almost 2 weeks ago. It’s a non event.

My take on CLVR is it will not trade much below 8, which equates to an EV of 180M. With an original $130M invested capital in the company and $80M cash providing them about a 2 year buildup runway, I think shares available below 8 would be quickly snapped up assuming the stock market is not about to collapse.

I also do not expect the stock to trade above the 12 - 14 strong resistance range possibly for the rest of 2021 unless a major catalyst materializes (or the sector becomes a momentum trade again...admittedly unlikely without decriminalization). If CLVR continues to announce middle of the road pharma partnerships the market will yawn because the lead times are exceptionally long, upwards of 1.5 to 2 years before potential revenues materialize. I also don’t expect much from the cbd product they’re developing for their Herbal brands distribution.

There are frankly only two catalysts that change this range bound theory imo. US decriminalization with a path for CLVR to import/partner or a significant partnership announcement with retail cpg in one of the legal markets. Just because they make medicinal grade product doesn’t mean it can’t be sold downstream into any number of speedier to market non medicinal retail channels. Without a major catalyst the Clever Leaves engine is on idle. So, after starting off quite bullish (thanks to their very misleading investor presentation) I’ve seen the error of my ways and am neutral to mildly bullish near to medium term and far more bullish further out as CLVR becomes a real cog in the global supply chain. That’s my take for now...

[diduknow]

Went thru the books and records, reports. I agree, I have been having fun with the candlestick fetish man. My sincere apologies. However, Mr. Candlestick posts on multiple sites about, well, candlesticks, what else. He has one in his hiney now. Now I predict more losses, increasing receivables, and more than likely, an SEC filing on a delay in quarterly report in a few days, or the report itself showing this. Of course, along with newly restated financials showing warrants as a liability,not an asset.

[kahlua]

Apparently this tiny rather unintelligible ego war continues here sans technical or fundamental due diligence on the actual company to support their positions.

[diduknow]

Heck, I rode this pig down from 15 and closed out all positions, thanks for the candlestick readings. There is always an ass for every seat and in this case, well, that ass is yours. You are now officially the bagholder of last resort for quite some time. Hang on for the restated balance sheet and I suspect, a delay in the first quarter LOSS report. LOLOLOL! P.S> the only candlestick you should be playing with is u'r own, heres to hoping you are double jointed, cheers.

[misteroldman]

Ok child. You must be so lonely.

Mmm mmm mmm loved those sub 9s... So you even have any money left? You bag holder lol.

[diduknow]

I know long term traders do not post delusionally all day about candlesticks they either cannot read or obviously failed, keep picken' bottoms, get a stinky fingers and you'll be back in mommies basement faster than you left. LOL! Dillweed.

[misteroldman]

Doji was bearish. Hope smart money sold end of day before another run down. Now we should go under $9 after earning report considering shorts are relentless. No retail can beat MMs long term. Until this moves north, best to flip and accumulate long term shares. Mmm mmm mmm love making money. Love free shares. Too bad diduknow... you aren't good enough to know how to do that diduknow... Lol you bag holder. Now this is the last time I ever recognize you as anything but a troll and a worthless novice bag holding wannabe trader sitting at home living in their parents basement still. ROFL you child.

You see us professionals use candlesticks to confirm mid day or openings. Not long term posts moron. we pros hold free long-term shares because we flip to make free long-term shares you, you just sit in troll hoping you find the bottom to jump in which you try to do that earlier but clearly you're a bag holder now and mad.. you mad bro?

Diduknow you know nothing? You troll. ROFL. Diduknow, you clearly don't know anything you're clearly a troll if you knew charting you know a doji hammer can be bullish or bearish gap the NEXT TRADING DAY, and then you would know that candlestick charting is just an addition to charting... no one trades off candlesticks alone long term... no one trades off just charting either... but charting is taking all forms with a william percentage and the RSI levels and taking everything into consideration. But you are so novice you wouldn't know that you clearly are some retail gen z or millennial who lost their job from the pandemic and his trading their $500 trying to go to the Moon. you're pathetic kid

[diduknow]

He who pick bottom all time get stinky fingers. Confucius.

[diduknow]

LOL, the candlestick man is back, goin to 12 tomorrow, triple bottoms, doji won kanoji. Never mind making money or having earnings and customers. Bwhahahaha.

[misteroldman]

Chart looks bullish imo and we hopefully touch or blast past the SMA 20 and try to tap the SMA 50.

[misteroldman]

Tomorrow will be interesting

[misteroldman]

Yummm. Those low nines. Mmmm mmm mm.

[diduknow]

Happy Chompin, LOL!

[misteroldman]

Chomp chomp chomp Scooped up few thousand more shares under $10. Boom. Glta. Unreal, shorts love this thing. I am liking my position. With cannabis news coming short term, this about to go boom.

For any newbies, short term is anything inside 12 months... Kids these days freak if they don't see to the moonn with in a few days. Lol. Then panic sell.

[misteroldman]

ROFL you mad bro? You definitely a bag holder. What do you kids say... To the moon?? Lol. You troll

[kahlua]

What an oxymoron you are, claiming to be an old man yet rambling on with ROFLs and LOLs like a very young and uninformed dolt with little respect for others and no imagination outside of your black and white logic. Wow! Good luck with that!

[misteroldman]

ROFL what? LOL OMG DEAD. No one knows what you just typed. Sounds like you have a negative stance, good luck with that kiddo, LOL

[misteroldman]

Fingers crossed. So glad added a few more under $10! wooohoooooo average of 10.05 now. CLVR ready to go up up up. holding long term. glta

[kahlua]

I do not believe decriminalization and a medically legal cannabis framework in the US. is priced into the current 250M EV for CLVR. If Schumer really does bring his bill to the floor in a few weeks, the risk off marijuana sector trade could certainly be in for an about face.

[kahlua]

I think the Senate will back down toward what Biden wants
(link below), which would be a great scenario for CLVR.

https://www.marijuanamoment.net/biden-wont-commit-to-sign-marijuana-bill-if-passed-by-congress-press-secretary-says/

[MRDALE]

Looks like Schumer did it - now all ya gotta do is get it past the Senate!!! GO $CLVR

[diduknow]

el florecimiento está fuera de la rosa- 7.198M

[misteroldman]

TIME FOR SOME 420 NEWS!!!!!!!

[misteroldman]

Let's go schumer!

[misteroldman]

ROFL WOWZA you must feel really stupid diduknow. I TOLD YOU diduknow knows NOTHING. MORON complete MORON you are diduknow

[misteroldman]

SEC FILING. IS THIS THE COMPLETION OF ERASING THE DEBT COMPLETELY AND FOR GOOD?

https://sec.report/Document/0001213900-21-020821/

[misteroldman]

NEWS COMING!!!! Going to Break $11 today do you think we see these levels again? Not if Schumer news hits!!!! It is Coming!! GLTA

[misteroldman]

ROFL u must be so mad bro, holding a big bag over there? Give it up child, grow up and go back to school. you are uneducated and probably living in your parents basement and anywhere from 20-35 years lol. Pathetic, everyone knows you just a troll bag holder kiddo. keep hoping lol

[diduknow]

Fabulous, by the time that happens, not for years with regulations and local concerns, you'll have financed the entire shop for pennies on the dollar for the ultimate buyer, you know the man, not the chumps.

[misteroldman]

In this episode, special guest Kyle Detwiler, CEO of Clever Leaves ($CLVR), joins the show to discuss the massive deal with Canopy Growth (a cannabis company based in Smiths Falls, Ontario). Clever Leaves agreed to a regional supply deal with Canopy Growth & then gained an EU GMP certification, which would allow the company to supply international markets as more countries might be eyeing cannabis legalization.

[misteroldman]

like clockwork the MMs took this to 9.85. this is double bottom confirmation for big money to get in now before Senate passes Schumer bill.

[diduknow]

Agreed, the big money will buy assets you guys payed 10 bux for pennies on the dollar and then change the rules and regs after. Suckers unite, once all the hard work is done, the big money will thank the little pleb's, as always, and swoop in. You are the cap ex guys, you pay the bills, set it all up, lose money and then.......LOLOLOL

[misteroldman]

Cannabis sector is gearing up for a massive run up. EVERYONE KNOWS NEWS COMING about Schumer bill to pass and we need taxes with federal medical cannabis and allow states to tax how they please. This is going to catapult this industry and we will NEVER see the industry so cheap. THIS IS MMs PLAYING GAMES SO BIG MONEY CAN GET IN CHEAP BEFORE THIS MASSIVE RUN UP. GLTA JMHO HUGE SECTOR NEWS COMING SOON!!!!